Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bouros

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Respiratory Medicine|April 7, 2009
Epidemiology of interstitial lung diseases in GreeceA Karakatsani, D Papakosta, A Rapti, et al.
Seminars in Oncology|August 1, 1997
Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancerV Georgoulias, C Kourousis, N Androulakis, et al.
Lung|June 11, 2011
Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parametersD Papakosta, G Pitsiou, Z Daniil, et al.
The European Respiratory Journal|December 7, 2007
Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic [corrected] studyC E Papadopoulos, G Pitsiou, T D Karamitsos, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 15, 2015
Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary FibrosisP Ntolios, N Papanas, E Nena, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 1998
Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung CancerV Georgoulias, N Androulakis, D Bouros, et al.
The European Respiratory Journal. Supplement|January 31, 2002
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown originG M Verleden, R M du Bois, D Bouros, et al.
Seminars in Oncology|August 1, 1997
Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary resultsV Georgoulias, C Kourousis, N Androulakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trialV Georgoulias, C Kouroussis, N Androulakis, et al.
European Review for Medical and Pharmacological Sciences|June 10, 2024
Elevated peripheral blood monocyte count is associated with prolonged postoperative hospitalization and functional decline in patients with interstitial lung diseases undergoing surgical lung biopsyT Karampitsakos, T Milas, P Tsiri, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Respiratory Medicine|April 7, 2009
Epidemiology of interstitial lung diseases in GreeceA Karakatsani, D Papakosta, A Rapti, et al.
Seminars in Oncology|August 1, 1997
Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancerV Georgoulias, C Kourousis, N Androulakis, et al.
Lung|June 11, 2011
Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parametersD Papakosta, G Pitsiou, Z Daniil, et al.
The European Respiratory Journal|December 7, 2007
Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic [corrected] studyC E Papadopoulos, G Pitsiou, T D Karamitsos, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 15, 2015
Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary FibrosisP Ntolios, N Papanas, E Nena, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 1998
Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung CancerV Georgoulias, N Androulakis, D Bouros, et al.
The European Respiratory Journal. Supplement|January 31, 2002
Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown originG M Verleden, R M du Bois, D Bouros, et al.
Seminars in Oncology|August 1, 1997
Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary resultsV Georgoulias, C Kourousis, N Androulakis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trialV Georgoulias, C Kouroussis, N Androulakis, et al.
European Review for Medical and Pharmacological Sciences|June 10, 2024
Elevated peripheral blood monocyte count is associated with prolonged postoperative hospitalization and functional decline in patients with interstitial lung diseases undergoing surgical lung biopsyT Karampitsakos, T Milas, P Tsiri, et al.
Pageof 13